AD/PD 2026 | Representation of diverse populations in AD research

Sid O’Bryant, PhD, Institute for Translational Research at UNT Health, Fort Worth, TX, discusses the importance of representation of diverse populations in Alzheimer’s disease (AD) research. Dr O’Bryant emphasizes the need for a community-based approach, building trust and relationships with communities to increase participation in research programs and ensure that novel therapies and biomarkers are accessible to all. This interview took place at the AD/PD™ 2026 International Conference on Alzheimer’s and Parkinson’s Diseases in Copenhagen, Denmark.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.